Docsity
Docsity

Prepare for your exams
Prepare for your exams

Study with the several resources on Docsity


Earn points to download
Earn points to download

Earn points by helping other students or get them with a premium plan


Guidelines and tips
Guidelines and tips

Nursing Process: Medication Management for Atorvastatin, Cholestyramine, and Gemfibrozil, Study notes of Nursing

The nursing process for patients receiving atorvastatin (lipitor), cholestyramine (questran), and gemfibrozil. It includes assessment, potential nursing diagnoses, patient goals and expected outcomes, implementation with interventions and rationales, and evaluation of outcome criteria for each medication. The focus is on patient education, monitoring side effects, and ensuring adherence to medication schedules and lifestyle modifications.

Typology: Study notes

2021/2022

Uploaded on 09/27/2022

teap1x
teap1x 🇺🇸

4.7

(17)

231 documents

1 / 4

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Nursing Process Focus:
Patients Receiving Atorvastatin (Lipitor)
Assessment
Prior to administration:
Obtain complete health history including
allergies.
Assess baseline liver function tests, lipid
studies, and pregnancy test in women of
child bearing age
Assess for history of liver disease, muscle
disease
Obtain patient’s drug history including
use of over the counter medications that
might effect liver function or have
interactions and assess allergies
Potential Nursing Diagnoses
Health Maintenance, Ineffective related to
insufficient knowledge of actions and
effects of prescribed drug therapy
Knowledge deficient related to need for
altered lifestyle
Planning: Patient Goals and Expected Outcomes
The patient will:
Demonstrate the expected outcome of drug therapy and list reportable side effects.
Demonstrate adherence to prescribed lifestyle changes
Implementation
Interventions and (Rationales) Patient Education/Discharge Planning
Monitor for concurrent alcohol use.
(Alcohol may affect liver function.)
Advise patient to avoid or limit alcohol
use.
Encourage smoking cessation. (Smoking
may decrease HDL levels and thereby
counteract effects of medication.)
Advise patient to seek methods to stop
smoking.
Evaluate reports of vision changes. (Drug
may cause photosensitivity.)
Instruct patient to:
Avoid prolonged sun or UV exposure.
Use sunglasses, wear protective clothing,
and use sunscreen.
Monitor blood cholesterol and triglyceride
levels at intervals during therapy. After
beginning treatment levels are re-checked
in 2-3 months (to ascertain drug
effectiveness).
Inform patient of treatment plan.
Monitor compliance with dietary
modifications. (Dietary modification is
continued along with drug therapy.)
Instruct patient concerning the need to
continue low saturated fat, low cholesterol
diet.
Monitor CPK levels if muscle tenderness
or weakness develops.
Monitor liver function studies as these
drugs may affect liver function.
Advise patient to report to the lab for
scheduled blood tests.
pf3
pf4

Partial preview of the text

Download Nursing Process: Medication Management for Atorvastatin, Cholestyramine, and Gemfibrozil and more Study notes Nursing in PDF only on Docsity!

Patients Receiving Atorvastatin (Lipitor) Assessment Prior to administration:

  • Obtain complete health history including allergies.
  • Assess baseline liver function tests, lipid studies, and pregnancy test in women of child bearing age
  • Assess for history of liver disease, muscle disease
  • Obtain patient’s drug history including use of over the counter medications that might effect liver function or have interactions and assess allergies

Potential Nursing Diagnoses

  • Health Maintenance, Ineffective related to insufficient knowledge of actions and effects of prescribed drug therapy
  • Knowledge deficient related to need for altered lifestyle

Planning: Patient Goals and Expected Outcomes The patient will:

  • Demonstrate the expected outcome of drug therapy and list reportable side effects.
  • Demonstrate adherence to prescribed lifestyle changes Implementation Interventions and (Rationales) Patient Education/Discharge Planning
  • Monitor for concurrent alcohol use. (Alcohol may affect liver function.)
  • Advise patient to avoid or limit alcohol use.
  • Encourage smoking cessation. (Smoking may decrease HDL levels and thereby counteract effects of medication.)
  • Advise patient to seek methods to stop smoking.
  • Evaluate reports of vision changes. (Drug may cause photosensitivity.)

Instruct patient to:

  • Avoid prolonged sun or UV exposure.
  • Use sunglasses, wear protective clothing, and use sunscreen.
  • Monitor blood cholesterol and triglyceride levels at intervals during therapy. After beginning treatment levels are re-checked in 2-3 months (to ascertain drug effectiveness).
  • Inform patient of treatment plan.
  • Monitor compliance with dietary modifications. (Dietary modification is continued along with drug therapy.)
  • Instruct patient concerning the need to continue low saturated fat, low cholesterol diet.
  • Monitor CPK levels if muscle tenderness or weakness develops.
  • Monitor liver function studies as these drugs may affect liver function.
  • Advise patient to report to the lab for scheduled blood tests.

Evaluation of Outcome Criteria Evaluate the effectiveness of drug therapy by confirming that patient goals and expected

Patients Receiving Gemfibrozil

Assessment Prior to administration

  • Assess baseline lipid studies, PT / INR if on coumadin, blood glucose, liver function tests, and CBC
  • Assess for history of gallbladder disease or hepatic dysfunction
  • Obtain patient’s drug history including use of over the counter medications and assess allergies

Potential Nursing Diagnoses

  • Knowledge deficient related to drug therapy
  • Noncompliance related to side effects
  • Noncompliance related to prolonged therapy

Planning: Patient Goals and Expected Outcomes The patient will:

  • Comply with prescribed medication schedule and regimen.
  • Demonstrate knowledge of drug therapy Implementation Interventions and (Rationales) Patient Education/Discharge Planning
  • Monitor for safety (medication may cause dizziness and blurred vision)
  • Monitor for the following adverse effects: severe stomach pains nausea & vomiting, fever chills sore throat, diarrhea, or muscle cramping. Report immediately.

Instruct patient to:

  • Use caution when driving or performing other dangerous tasks until drug effects are known.
  • Report any adverse effects to a health care provider immediately: severe stomach pains nausea & vomiting, fever chills sore throat, diarrhea, or muscle cramping
  • Monitor triglyceride and cholesterol levels during therapy (to evaluate effectiveness of drug therapy).
  • Instruct patient to report to lab for periodic blood tests to evaluate response to drug.
  • Monitor PT/INR closely of patients taking coumadin (dose alteration may be needed). Monitor skin for petechiae or ecchymosis (may indicate abnormal clotting times).

Advise patient

  • Of the importance of monitoring coagulation due to interaction with gemfibrozil.
  • To report bruising to the health care provider
  • Monitor diet (medication should be used in conjunction with a diet low in cholesterol and fat)
  • Inform patient regarding the possible need to adjust dietary habits to include low cholesterol/low fat foods Evaluation of Outcome Criteria Evaluate the effectiveness of drug therapy by confirming that patient goals and expected